Patent details

Basic Information

Publication number:

EP2027157

PCT Application Number:

PCT/EP/2007/055029

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077867190

PCT Publication Number:

WO/2007/137984

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED HUMANISED ANTI-INTERLEUKIN-18 ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-INTERLEUKINE-18, MODIFIES ET HUMANISES

German Title of Invention:

MODIFIZIERTE HUMANISIERTE ANTI-INTERLEUKIN-18 ANTIKÖRPER

SPC Number:

Dates

Filing date:

23/05/2007

Grant date:

06/08/2014

EP Publication Date:

06/08/2014

PCT Publication Date:

06/12/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/02/2009

EP B1 Publication Date:

06/08/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/05/2015

Expiration date:

23/05/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/05/2007

 

 

Name:

Glaxo Group Limited

Address:

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Inventor

1

Name:

ELLIS Jonathan Henry

Address:

United Kingdom (GB)

2

Name:

KIRBY Ian

Address:

United Kingdom (GB)

3

Name:

GERMASCHEWSKI Volker

Address:

United Kingdom (GB)

4

Name:

HAMBLIN Paul Andrew

Address:

United Kingdom (GB)

Priority

1

Priority Number:

0610438

Priority Date:

25/05/2006

Priority Country:

United Kingdom (GB)

2

Priority Number:

0611046

Priority Date:

05/06/2006

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07K 16/24;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages